Abstract
Antibiotics are not indicated for the treatment of bronchitis and bronchiolitis. Using a nationally-representative database from 2006–2015, we found antibiotics were prescribed in 58% of outpatient visits for bronchitis and bronchiolitis in children, serving as a possible baseline for the expanded HEDIS 2020 measure regarding antibiotic prescribing for bronchitis.
Introduction.
Bronchitis and bronchiolitis are common lower respiratory tract infections resulting in unnecessary antibiotic prescriptions.1 Clinical practice guidelines define bronchiolitis as occurring in children <2 years, while bronchitis is often diagnosed in children ≥2.2,3 Antibiotics are not recommended for either diagnosis, as most of these infections are viral,2,3 but antibiotics are frequently prescribed to children with these diagnoses.1 Reducing unnecessary antibiotic use is important: antibiotics are the leading cause of emergency department (ED) visits for pediatric adverse drug events and contribute to antibiotic resistance.4
A Healthcare Effectiveness Data and Information Set (HEDIS) measure regarding antibiotic prescribing for adult acute bronchitis began in 2006; a study of this measure found antibiotics were prescribed in 76% of adult bronchitis visits.5 This measure has recently expanded to include children and bronchiolitis diagnoses.6 We aimed to characterize antibiotic prescribing for acute bronchitis and bronchiolitis in pediatric visits to EDs, pediatrician offices, and family medicine physician offices in the United States from 2006–2015 as a baseline for the expanded HEDIS measure.
Methods.
We used the 2006–2015 National Ambulatory Medical Care Survey (NAMCS) and National Hospital Ambulatory Medical Care Survey (NHAMCS) to estimate pediatric (0–18 years) acute bronchitis and bronchiolitis visits and associated antibiotic prescribing. These nationally-representative surveys, conducted by the National Center for Health Statistics, estimate visits to non-federal, office-based physicians (NAMCS) and hospital EDs (NHAMCS) using sampled visits and sampling weights, as previously described.1 We limited the study to 2006–2015 due to changes in diagnostic coding in NAMCS/NHAMCS in 2016. All study years included use of International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) diagnostic codes.
In NAMCS/NHAMCS, visits may contain multiple diagnosis codes and medications. Analysis was limited to the first three diagnosis codes and the first eight drug mentions (prescribed, continued, or provided) for consistency across years of data. We identified visits with bronchitis (ICD-9-CM codes 466.0, 490.0) and bronchiolitis (466.11, 466.19) as the first-listed diagnosis. We excluded visits with codes for diagnoses where antibiotics are or may be indicated using a previously described classification scheme.1 We additionally excluded visits with diagnostic codes for chronic bronchitis, emphysema, or chronic obstructive pulmonary disease (491*, 492*, 496). Visits with referrals to higher acuity settings (NAMCS: ED, hospital referral; NHAMCS: hospital admission) were also excluded to mirror the HEDIS measure. We defined oral and parenteral antibiotic prescriptions as anti-infective drugs excluding topical medications, amebicides, leprostatics, anti-helminthics, antifungals, antivirals, antimalarials, and anti-tuberculosis medications.
We estimated national annual average and 95% confidence intervals (CI) of the number of visits and antibiotic prescriptions for bronchitis and bronchiolitis for the ten-year study period (2006–2015) using survey weighting procedures to account for the complex survey design. The estimates were made overall, by condition, sex, U.S. census region (Northeast, Midwest, South, West), clinician specialty (pediatrics, family medicine, emergency department), and setting (emergency department, physician office). As bronchiolitis should be diagnosed only in children <24 months of age,3 estimates were also made by age group (<2, 2–18 years). We calculated the proportions of visits with antibiotic prescriptions overall and by strata. To assess for trends in prescribing during the study period, we conducted a chi-square test comparing the proportion of visits in which antibiotics were prescribed in each year. The association between visit setting and clinician specialty (combined into one variable) and antibiotic prescriptions, adjusting for age category, diagnosis (bronchitis, bronchiolitis), and region was estimated using multivariable logistic regression. Estimates were not calculated if there were <30 unweighted observations or the relative standard error was >30%.
All statistical analyses were conducted using SAS 9.4 (SAS Institute Cary, NC) and alpha=0.05. NAMCS/NHAMCS are de-identified, publicly-available datasets exempt from institutional review board requirements as determined by the Centers for Disease Control and Prevention’s National Center for Emerging and Zoonotic Infectious Diseases human subjects advisor.
Results.
During the ten-year study period, there was an annual average of 2,979,460 (95% CI: 2,521,463–3,437,458) visits for bronchitis and bronchiolitis among children 0–18 years (Table 1). Antibiotics were prescribed in 57.9% (95% CI: 53.2%−62.5%) of these visits, equivalent to 1,724,667 prescriptions annually. The proportion of visits with antibiotic prescriptions did not vary significantly by year during the study period (p=0.18; Supplemental Table 1).
Table 1.
Visits and Antibiotic Prescriptions for Bronchitis and Bronchiolitis in EDs and Physician Offices, Children 0–18 Years, US NAMCS/NHAMCS, 2006–2015
| <2 Years | 2–18 Years | All Children | ||||
|---|---|---|---|---|---|---|
| National Weighted Estimated Annual Average Number of Visits for Diagnosis (95% CI) for 2006–2015 | % Visits with Antibiotics Prescribed (95% CI)a | National Weighted Estimated Annual Average Number of Visits for Diagnosis (95% CI) for 2006–2015 | % Visits with Antibiotics Prescribed (95% CI)a | National Weighted Estimated Annual Average Number of Visits for Diagnosis (95% CI) for 2006–2015 | % Visits with Antibiotics Prescribed (95% CI)a | |
| Total | 1,069,200 (878,672, 1,259,728) | 40.31 (33.78, 46.84) | 1,910,261 (1,574,424, 2,246,097) | 67.72 (62.14, 73.30) | 2,979,460 (2,521,463, 3,437,458) | 57.89 (53.24, 62.53) |
| Diagnosis | ||||||
| Bronchitisb | 527,473 (399,976, 654,971) | 61.30 (53.39, 69.20) | 1,814,064 (1,478,957, 2,149,170) | 69.61 (63.88, 75.34) | 2,341,537 (1,921,836, 2,761,237) | 67.74 (62.58,72.90) |
| Bronchiolitisc | 541,727 (414,252, 669,202) | 19.87 (12.70, 27.04) | 96,197 (55,498, 136,896) | * | 637,924, (494,600, 781,247) | 21.72 (14.28, 29.16) |
| Sex | ||||||
| Male | 630,608 (508,735, 752,481) | 37.79 (29.55, 46.03) | 928,236 (748,795, 1,107,676) | 70.07 (63.39, 76.75) | 1,558,844 (1,314,879, 1,802,809) | 57.01 (51.57, 62.46) |
| Female | 438,592 (331,271, 545,913) | 43.93 (33.40, 54.45) | 982,025 (779,217, 1,184,832) | 65.50 (57.03, 73.98) | 1,420,617 (1,153,978, 1,687,255) | 58.84 (52.32.65.36) |
| Region | ||||||
| Northeast | 154,291 (60,715, 247,868) | 34.29 (21.54, 47.03) | 300,038 (175,631, 424,444) | 77.27 (68.25, 86.30) | 454,329 (254,681, 653,977) | 62.67 (55.02, 70.33) |
| Midwest | 178,682 (120,657, 236,707) | 40.37 (22.99, 57.75) | 331,695 (235,699, 427,690) | 72.29 (63.46, 81.12) | 510,377 (384,796, 635,957) | 61.11 (52.28, 69.95) |
| South | 431,123 (311,617, 550,630) | 41.37 (30.63, 52.10) | 850,602 (625,996, 1,075,208) | 69.08 (61.75, 76.41) | 1,281,725 (998,495, 1,564,955) | 59.76 (52.71, 66.81) |
| West | 305,103 (205,623, 404,583) | 41.83 (29.71, 53.94) | 427,926 (233,900, 621,953) | 54.80 (39.56, 70.03) | 733,030 (461,158, 1,004,901) | 49.40 (37.98, 60.82) |
| Setting | ||||||
| Emergency Department | 240,828 (202,060, 279,597) | 26.59 (19.90, 33.28) | 297,910 (256,694, 339,126) | 58.55 (52.69, 64.40) | 538,739 (474,140, 603,337) | 44.26 (39.46, 49.06) |
| Physician Office | 828,372 (639,661, 1,017,082) | 44.30 (36.32, 52.28) | 1,612,350 (1,287,754, 1,936,947) | 69.42 (62.86, 75.98) | 2,440,722 (1,995,356, 2,886,087) | 60.89 (55.36, 66.42) |
| Clinician Specialty | ||||||
| Pediatrics | 729,482 (553,575, 905,389) | 41.78 (33.39, 50.17) | 992,911 (751,858, 1,233,963) | 66.43 (57.47, 75.38) | 1,722,393 (1,367,114, 2,077,671) | 55.99 (49.16, 62.82) |
| Family Medicine | * | * | 503,943 (356,397, 651,489) | 73.00 (63.33, 82.69) | 601,950 (437,031, 766,868) | 71.45 (62.49, 80.42) |
| Emergency Department | 240,828 (202,060, 279,597) | 26.59 (19.90, 33.28) | 297,910 (256,694, 339,126) | 58.55 (52.69, 64.40) | 538,739 (474,140, 603,337) | 44.26 (39.46, 49.06) |
Calculated as number of visits for diagnoses with an antibiotic prescription as the numerator and the total number of visits for diagnoses as the denominator
ICD-9-CM codes 466.0 or 490.0 in the primary position with no other codes in any coding position for a diagnosis where antibiotics are or may be indicated
ICD-9-CM codes 466.11 or 466.19 in the primary position with no other codes in any coding position for a diagnosis where antibiotics are or may be indicated
Sample size does not meet standards for reliability (<30 sampled visits)
Antibiotics were less frequently prescribed in bronchitis and bronchiolitis ED visits (44.3%, 95% CI: 39.5%−49.1%) than office visits (60.9 %, 95% CI: 55.4%−66.4%). Among office visits, antibiotics were prescribed in 71.5% (95% CI: 62.5%−80.4%) of family medicine physician visits and 56.0% (95% CI: 49.2%−62.8%) of pediatrician visits. ED visits were 36% less likely to result in antibiotic prescriptions than pediatrician office visits, adjusting for age, diagnosis, and region (aOR: 0.64, 95% CI: 0.46–0.91; Table 2). The likelihood of an antibiotic prescription was slightly, but not significantly higher among office visits to family medicine physicians compared to pediatricians (Table 2).
Table 2.
Association Between Clinician Specialty and Setting and Antibiotic Prescription
| OR (95% CI) For Antibiotic Prescription by Clinician Specialty and Setting | ||
|---|---|---|
| Clinician Specialty/Setting: | Univariate Associationa | Multivariate Associationb |
| Physician Office-Pediatrician | Referent | Referent |
| Physician Office-Family Medicine | 1.97 (1.18, 3.29) | 1.35 (0.78, 2.33) |
| Emergency Departmentc | 0.62 (0.45, 0.87) | 0.64 (0.46, 0.91) |
Unadjusted
Adjusted for age category, diagnosis of bronchitis versus bronchiolitis, and region
NHAMCS does not include specialty information for emergency department visits
Discussion.
Although not indicated for acute bronchitis and bronchiolitis, antibiotics were prescribed in 57.9% of pediatric visits to physician offices and EDs for these diagnoses in the United States from 2006 to 2015, leading to over 1.7 million unnecessary antibiotic prescriptions annually. Although prescribing was lower in EDs than offices, improvement is needed across settings and specialties. Our findings provide a baseline for pediatric antibiotic use for the expanded HEDIS 2020 measure regarding antibiotic treatment for acute bronchitis/bronchiolitis.6 Expansion of this measure may help drive improvements in antibiotic prescribing in children. Previous studies have found high rates of antibiotic prescribing for these diagnoses: 25% in pediatric ED visits for bronchiolitis and 76% in adults with bronchitis.5,7
Visits to emergency departments were significantly less likely to result in antibiotic prescriptions than office visits to pediatricians. This may have been impacted by the high proportion of children <2 years seen in EDs compared to physician offices (45% versus 34%) combined with lower prescribing in this age group compared with older children (40% versus 68%). Similar trends were previously observed in a study of bronchitis management.8 However, antibiotics were still prescribed in over 40% of ED visits for these conditions.
Patient pressure has been cited as a major reason clinicians prescribe unnecessary antibiotics.9 Another possible factor contributing to inappropriate prescribing is diagnostic uncertainty, which could lead physicians to treat patients diagnosed with bronchitis as if they have bacterial pneumonia, a condition for which antibiotics are indicated, although our analysis excluded visits with pneumonia co-diagnoses. The CDC’s Core Elements of Outpatient Antibiotic Stewardship provides evidence-based strategies for implementing antibiotic stewardship interventions,10 which may be leveraged to address unnecessary prescribing for acute bronchitis and bronchiolitis.
Our study had several limitations. Due to NAMCS/NHAMCS sampling frames, the analysis was limited to EDs and physician offices and nationally representative estimates by prescriber type (MD, Nurse Practitioner, Physician Assistant) were not possible, however HEDIS measures can be used to assess differences among specialties and provider types across settings. Additionally, diagnostic assignment relied solely on diagnostic codes. Chest x-ray use was not assessed, as it is not recommended for these conditions,3 although this could have impacted prescribing. Strengths of our study include the ability to generate nationally representative estimates.
We found that antibiotics were prescribed in the majority of visits for bronchitis and bronchiolitis in children from 2006–2015, even though antibiotics are not indicated for these diagnoses. High antibiotic prescribing for bronchitis and bronchiolitis persists across settings and specialties, highlighting an important antibiotic stewardship opportunity.
Supplementary Material
Acknowledgments.
We would like to thank Dr. Monina Bartoces for her input on statistical analyses.
Funding: This work was supported by the Centers for Disease Control and Prevention.
Footnotes
Disclaimer: The findings and conclusions in this manuscript are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
Potential conflicts of interests: Ms. Snyder and Ms. King are contractors employed by Northrop Grumman Corporation to fulfill research needs at the Centers for Disease Control and Prevention as part of a contract covering many positions and tasks. All other authors report no conflicts.
References.
- 1.Fleming-Dutra KE, Hersh AL, Shapiro DJ, et al. Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010–2011. JAMA. 2016;315(17):1864–1873. [DOI] [PubMed] [Google Scholar]
- 2.Hersh AL, Jackson MA, Hicks LA, American Academy of Pediatrics Committee on Infectious Diseases. Principles of judicious antibiotic prescribing for upper respiratory tract infections in pediatrics. Pediatrics. 2013;132(6):1146–1154. [DOI] [PubMed] [Google Scholar]
- 3.Ralston SL, Lieberthal AS, Meissner HC, et al. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics. 2014;134(5):e1474–1502. [DOI] [PubMed] [Google Scholar]
- 4.Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013.Available at: https://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf.Accessed May 7, 2019.
- 5.Roberts RM, Hicks LA, Bartoces M. Variation in US outpatient antibiotic prescribing quality measures according to health plan and geography. Am J Manag Care. 2016;22(8):519–523. [PMC free article] [PubMed] [Google Scholar]
- 6.National Committee for Quality Assurance. HEDIS 2020, Volume 2, Appendix 1: summary table of measures, product lines, and changes. Available at: https://www.ncqa.org/wp-content/uploads/2019/07/20190701_HEDIS_2020_Measures_Summary_of_Changes.pdf.Accessed September 17, 2019.
- 7.Papenburg J, Fontela PS, Freitas RR, et al. Inappropriate antibiotic prescribing for acute bronchiolitis in US emergency departments, 2007–2015. J Pediatric Infect Dis Soc. 2019;8(6):567–570. [DOI] [PubMed] [Google Scholar]
- 8.Agiro A, Gautam S, Wall E, et al. Variation in outpatient antibiotic dispensing for respiratoryinfections in children by clinician specialty and treatment setting. Pediatr Infect Dis J. 2018;37(12):1248–1254. [DOI] [PubMed] [Google Scholar]
- 9.Dempsey PP, Businger AC, Whaley LE, et al. Primary care clinicians’ perceptions about antibiotic prescribing for acute bronchitis: a qualitative study. BMC Fam Pract. 2014;15(1):194. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Sanchez GV, Fleming-Dutra KE, Roberts RM, et al. Core elements of outpatient antibiotic stewardship. MMWR Recomm Rep. 2016;65(6):1–12 [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.